CMPS compared with IMCR: revenue, margins and what each company keeps, and the suppliers and customers both name

CMPSCOMPASS Pathways plc

Mkt capRevenueRevenue

IMCRImmunocore Holdings plc

Mkt capRevenueRevenue

Compare

CMPSCOMPASS Pathways plc

IMCRImmunocore Holdings plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CMPS: latest quarter not drawable. IMCR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CMPS 0

None

Shared 0

No disclosed counterparties: CMPS.

Only IMCR 1

—Adaptimmune Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

CMPS, solidIMCR, dashed

CMPSCOMPASS Pathways plc

11.57▼−5.09%· post 11.62

Mkt cap$1.6BRevenue—Revenue—

IMCRImmunocore Holdings plc

30.46▼−2.60%· post 30.46

ClosedOct 30 '26

Mkt cap$1.6BRevenue$116MQ2 FY26Revenue$400MFY25

Compare

ClosedOct 30 '26

CMPSCOMPASS Pathways plc

IMCRImmunocore Holdings plc

11.57▼−5.09%post 11.62

Price

30.46▼−2.60%post 30.46

$1.6B

Mkt cap

$1.6B

—

Revenue

$116MQ2 FY26

—

Revenue

$400MFY25

CMPS11.57▼−5.09%vsIMCR30.46▼−2.60%ClosedOct 30 '26